Millions for Proteomics Research in the Peer Reviewed Medical Research Program
Millions for Proteomics Research in the Peer Reviewed Medical Research Program
How SomaLogic technologies can give your research programs an edge.
Topics Covered
- Overview of the Peer Reviewed Medical Research Program (PRMRP) and Congressionally Directed Medical Research Programs (CDMRP)
- Overview of SomaLogic technologies that can give your research programs an edge
- How the PRMRP application process is unique to other U.S. government grant programs
- “Best Practices” for a successful PRMRP application
Tammy Hicks
Tammy Hicks is the Associate Director for the Southeast U.S. for SomaLoigic and has over 24 years of experience leading, mentoring, and selling in the Life Sciences market. She has supported many sectors, including academic research centers, pharmaceutical companies, and diagnostic testing providers. Tammy’s understanding of research and how to translate research findings into practical, actionable information for patients and physicians alike has allowed her to assist with many projects that improve health outcomes and deepen our understanding of human biology.
Elizabeth Barrows
Elizabeth “Liz” Barrows is a federal funding consultant whose clients have secured in excess of $100M over the course of her 10+-year career. Liz’s in-depth knowledge of the Department of Defense (DoD) funding opportunities and needs has a basis in experience at the DoD, where she managed pharmaceutical research and development projects in, and reviewed proposals for, blood products, resuscitation fluids and analgesic drugs for the U.S. Army from 2004-2009. She has also worked with NASA and private industry on the development of biomedical sensors, robotics, in vitro diagnostics, and blood products. She holds a master’s degree in biomedical engineering.
Millions for Proteomics Research in the Peer Reviewed Medical Research Program
A presentation by Tammy Hicks and Elizabeth Barrows
More webinars
WebinarBoutique Webinar Aptamers with protein-like side chains as a versatile tool for high-content proteomics
Proteins, encoded in 20,000 genes in humans, do much of the work in biology. Measuring proteins, which change in response to various perturbations and represent targets for almost all drugs, offers insights about the health status of an organism. Since proteins operate in complex networks rather than in isolation, measuring multiple proteins simultaneously offers richer insights compared to single protein measurements.
WebinarUsing Proteomics To Advance Understanding of Alzheimer’s Disease
Limited understanding due to its complex pathophysiology and lack of definitive biomarkers currently constrains the diagnosis and treatment of Alzheimer’s disease (AD). But new research is uncovering dynamic brain changes during Alzheimer’s progression, offering potential therapeutic targets. This webinar explores how proteomics and systems biology can be integrated to elucidate AD pathology.
WebinarPredictive modeling and reliable biomarker discovery in clinical omics studies
High-content omic technologies coupled machine learning methods have transformed the biomarker discovery process. However, the translation of computational results into scalable clinical biomarkers remains challenging. A rate-limiting step is the rigorous selection of reliable biomarker candidates among a host of biological features. Drawing examples from real-world clinical omics studies, I will introduce Stabl, a general machine learning framework that identifies a sparse, reliable set of biomarkers by integrating noise injection and a data-driven signal-to-noise threshold into multivariable predictive modeling.